Newsletter | August 6, 2024

08.06.24 -- The Real Cost Of Poor Quality. And What To Do About It.

SPONSOR

FEATURED EDITORIAL

The Real Cost Of Poor Quality — And What You Should Do About It

By Samantha Atkinson, executive vice president and principal consultant, NSF

It is well recognized that poor quality can lead to supply disruption. To drive positive change, the sector should seek to greater enhance quality maturity.

INDUSTRY INSIGHTS

Top 5 Dos And Don'ts Of RTSM

Article | By James Stringer, Signant Health

Discover best practices and common pitfalls for sponsors and vendors in RTSM. Learn how to optimize your study by leveraging vendor expertise, avoiding delays, and embracing innovation for better outcomes.

Navigating New EU Clinical Trials Requirements For Clinical Supplies

Article | Catalent

Better understand Clinical Trials Regulation No. 536/201 (CTR) labeling changes and their potential to disrupt traditional clinical supply strategy that adhere to the new requirements.

Benefits Of Implementing EDC & Medical Coding With RTSM

Case Study | By Katie Neumann, Fountayn

Discover what happened when the Fountayn Platform, including RTSM, was used to support a client’s two-year, Phase III study seeking a cure for multiple sclerosis.

SOLUTIONS

Streamlining Clinical Supply With Advanced Automation

IQVIA Technologies

An Early-Phase, Raw-Material, Clinical Manufacturing Case Study

Cytiva